Navigation Links
Early-stage executives hear from investors

Milwaukee, Wis. - Angel and venture investors have fewer secrets these days, and they were more than willing to dispense some advice to early-stage executives during the National SBIR-STTR Conference.

In evaluating MatriLab, a Milwaukee-based biotech with scientific ties to the University of Wisconsin-Madison, they counseled technology start ups to......

Full article >>> tion of higher animal studies on pigs and further business development work.

George Arida, managing director of Venture Investors, liked the fact that MatriLab has established milestones, which is a sign to investors that some thought has been put into the development of the company. The same "stair step" approach will benefit the company when......

Full article >>> ter returns, Meier said it's not a bad idea for any technology company to start thinking about sales long before the product goes to market. If nothing else, talking to potential future customers will sharpen the sense of product validation.

"Before you even start your business," Meier said, "you should be making sales calls."

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 11/08/06


Related biology technology :

1. Early-stage quality brings investment, Meier says
2. Financial executives to launch Madison chapter
3. RoleFlow launches process-management software for executives
4. Brazilian bio-industry should impress American investors
5. Bio-energy and cleantech grab attention of investors
6. Angel investors commit $12.7B in first half of `06
7. Wisconsin investors the lifeblood of New Jersey biotech
8. California investors acquire RedPrairie Corp.
9. Wisconsin investors will make their pitch to IPIC
10. Winner of Burrill competition courted by North Carolina investors
11. Platypus raises $1.2 million from private investors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/15/2017)... 2017  Trianni, Inc. („TRIANNI") gab heute bekannt, ... Lizenzvereinbarung über die Verwendung der The Trianni Mouse ... die Entdeckung monoklonaler Antikörper. Die Trianni ... aus, das Janssen den Zugang zu ... das für die schelle Isolierung vollständig menschlicher Therapeutika ...
(Date:2/15/2017)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced ... and full year ended December 31, 2016. ... as we continued to demonstrate strong growth in ... Fanapt," said Mihael H. Polymeropoulos, M.D., Vanda,s President ... important 2017 milestones underscores Vanda,s commitment to bringing ...
(Date:2/15/2017)... Feb. 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, will ... presentation) at 8:00 AM EST on Thursday, February 16, ... clinical program, the recently announced closing of a $10.5 ... To participate in the live call and ...
(Date:2/15/2017)... ... February 15, 2017 , ... Diameter Health (Diameter) ... Health technology in the hands of Lantana analysts. The high-performance platform of Diameter ... public health entities – all those mining value from clinical data – to ...
Breaking Biology Technology:
(Date:1/21/2017)... Research and Markets has announced the addition ... to their offering. ... The global voice recognition biometrics market to grow at a ... report covers the present scenario and the growth prospects of the ... size, the report considers the revenue generated from the sales of ...
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/12/2017)... SAN DIEGO , Jan. 12, 2017  Trovagene, ... circulating tumor DNA (ctDNA) technologies, today announced that it ... Europe and the Middle ... biopsy tests.  This milestone marks the first wave of ... tests for urine and blood samples. The ...
Breaking Biology News(10 mins):